Evidence map›Paper›PMID 27562518›Full record

ArticleCell stress & chaperones2016

Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways.

Jian-Ming Zhou, Sha-Sha Gu, Wang Hong Mei, Jun Zhou, Zhen Zhong Wang, Wei Xiao

Open access · bronzeAbstract read
In one paragraph

Article in Cell stress & chaperones, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
10.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 74 citations in OpenAlex.

  1. Experimental and therapeutic medicine · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. OncogenicNeural regeneration research · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Glial Cells Response in Stroke.Cellular and molecular neurobiology · 2023
    Review
  18. TiOAdvances in neurobiology · 2023
    Review
  19. Molecules (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jian-Ming ZhouState Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Modern TCM Research Institute, Lianyungang, 222001, China. jianmin8920@163.com.
Sha-Sha GuState Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Modern TCM Research Institute, Lianyungang, 222001, China.
Wang Hong MeiState Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Modern TCM Research Institute, Lianyungang, 222001, China.
Jun ZhouState Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Modern TCM Research Institute, Lianyungang, 222001, China.
Zhen Zhong WangState Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Modern TCM Research Institute, Lianyungang, 222001, China.
Wei XiaoState Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Modern TCM Research Institute, Lianyungang, 222001, China.
Kanion Pharmaceutical (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginkgolide and bilobalide are major trilactone constituent of Ginkgo biloba leaves and have been shown to exert powerful neuroprotective properties. The aims of this study were to observe the inhibitory effects of ginkgolide and bilobalide on the activation of microglial cells induced by oxygen-glucose deprivation and reoxygenation (OGD/R) and the specific mechanisms by which these effects are mediated. For detecting whether ginkgolide and bilobalide increased cell viability in a dose-dependent manner, BV2 cells were subjected to oxygen-glucose deprivation for 4 h followed by 3 h reoxygenation with various concentrations of drugs (6.25, 12.5, 25, 50, and 100 μg/ml). The extent of apoptosis effect of OGD/R with or without ginkgolide and bilobalide treatment were also measured by Annexin V-FITC/PI staining. Similarly, the levels of pro-inflammatory cytokines TNF-α, IL-1β, IL-6, IL-8, and IL-10 were detected using a specific Bio-Plex Pro™ Reagent Kit. The effects of ginkgolide and bilobalide on protein levels of TLR2/4, MyD88, p-TAK1, p-IKKβ, p-IkBα, NF-κB p65, Bcl-2, Bax, Bak, RIP3, cleaved-Caspase-3, cleaved PARP-1 and cellular localization of NF-κB p65 were evaluated by Western blot and double-labeled immunofluorescence staining, respectively. OGD/R significantly decreased the cell viability and increased the release of IL-1β, IL-6, IL-8, IL-10, TNF-α in BV2 microglia cells; these effects were suppressed by ginkgolide and bilobalide. Meanwhile, ginkgolide and bilobalide also attenuated the OGD/R-induced increases in TLR2, TLR4, MyD88, Bak, RIP3 levels and reversed cleaved caspase-3/caspase-3, Bax/Bcl-2 and cleaved PARP-1/PARP-1 ratio. Furthermore, ginkgolide and bilobalide also downregulated p-TAK1, p-IkBα, and p-IKKβ and inhibited the OGD/R-induced transfer of NF-κB p65 from cytoplasm to nucleus in BV2 microglia cells. The results showed that ginkgolide and bilobalide can inhibit OGD/R-induced production of inflammatory factors in BV2 microglia cells by regulating the TLRs/MyD88/NF-κB signaling pathways and attenuating inflammatory response. The possible mechanism of anti-inflammatory and neuroprotective effects of ginkgolides results from the synergistic reaction among each monomer constituents.

Indexed as

AnimalsApoptosisCell HypoxiaCell LineCyclopentanesCytokinesEnzyme-Linked Immunosorbent AssayFuransGinkgolidesGlucoseMiceMicrogliaMicroscopy, FluorescenceMyeloid Differentiation Factor 88Neuroprotective AgentsSignal TransductionbilobalideCyclopentanesCytokinesFuransGinkgolidesGlucoseMyd88 protein, mouseMyeloid Differentiation Factor 88Neuroprotective AgentsRela protein, mouseToll-Like Receptor 2Toll-Like Receptor 4Transcription Factor RelABilobalideBV2 microglia cellsCerebral ischemiaGinkgolidesInflammatoryNF-κBTLRs

Identifiers

PMID27562518
PMCPMC5083673
OpenAlexW2512139777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.